| Issue |
Section |
Title |
File |
| Vol 10, No 1 (2014) |
REVIEW |
INTERMITTENT HORMONE THERAPY WITH ELIGARD IN PATIENTS WITH PROSTATE CANCER |
(Rus)
|
| Vol 10, No 1 (2014) |
CLINICAL CASE |
THE ATYPICAL SITE OF URETERAL METASTASIS IN A PATIENT WITH CASTRATION-REFRACTORY PROSTATE CANCER. A CLINICAL CASE AND A REVIEW OF LITERATURE |
(Rus)
|
| Vol 9, No 2 (2013) |
CLINICAL CASE |
DIAGNOSIS AND TREATMENT OF METACHRONOUS TESTICULAR CANCER: A CLINICAL CASE |
(Rus)
|
| Vol 9, No 3 (2013) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
IDENTIFICATION OF PROGNOSTIC FACTORS OF THE EFFICIENCY OF BEVACIZUMAB THERAPY IN PATIENTS WITH METASTATIC RENAL-CELL CANCER |
(Rus)
|
| Vol 9, No 3 (2013) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
USE OF A COMBINATION OF АVASTIN AND LOW-DOSE INTERFERON- α IN THE FIRST-LINE TREATMENT OF METASTATIC RENAL-CELL CANCER |
(Rus)
|
| Vol 5, No 2 (2009) |
LECTURE |
PROGNOSTIC FACTORS IN PATIENTS WITH RENAL-CELL CARCINOMA AND A ROLE OF ONCOPHAGE IN INCREASING SURVIVAL RATES AFTER SURGICAL TREATMENT |
(Rus)
|
| Vol 7, No 3 (2011) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
EFFICIENCY OF USING A COMBINATION OF AVASTIN AND LOW-DOSE INTERFERON-Α2A IN THE TREATMENT OF METASTATIC RENAL CELL CARCINOMA |
(Rus)
|
| Vol 5, No 3 (2009) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
NEW CAPACITIES OF TARGETED THERAPY FOR METASTATIC RENAL-CELL CARCINOMA |
(Rus)
|
| Vol 6, No 3 (2010) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
EVEROLIMUS IN THE TREATMENT FOR METASTATIC RENAL CANCER |
(Rus)
|
| Vol 8, No 2 (2012) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
LAPAROSCOPIC NEPHRECTOMY USING RADIOFREQUENCY THERMAL ABLATION |
(Rus)
|
| Vol 8, No 3 (2012) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
EFFICIENCY OF TARGETED THERAPY USED IN THE HETEROGENEOUS POPULATION OF PATIENTS WITH METASTATIC KIDNEY CANCER |
(Rus)
|
| Vol 6, No 4 (2010) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
SEQUENTIAL USE OF TARGET AGENTS AND THEIR COMBINATION IN THE TREATMENT FOR METASTATIC RENAL CELL CARCINOMA |
(Rus)
|
| Vol 10, No 3 (2014) |
REVIEW |
Axitinib in the successive targeted therapy of patients with metastatic kidney cancer |
(Rus)
|
| Vol 10, No 4 (2014) |
PROSTATE CANCER |
Luteinizing hormone-releasing hormone antagonists in patients with prostate cancer. A standard approach and the results of innovative studies |
(Rus)
|
| Vol 11, No 2 (2015) |
LECTURE |
Neoadjuvant targeted therapy in patients with renal cell carcinoma |
(Rus)
|
| Vol 12, No 1 (2016) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Use of sunitinib in patients with metastatic kidney cancer in real clinical practice |
(Rus)
(Eng)
|
| Vol 15, No 3 (2019) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Efficacy and safety of lenvatinib in combination with everolimus in metastatic renal cell carcinoma resistant to antiangiogenic targeted therapy: Russian multicenter observational study ROSLERCM |
(Rus)
|
| Vol 3, No 1 (2007) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS |
Use of erythropoietins in oncourological care |
(Rus)
|
| Vol 2, No 3 (2006) |
DIAGNOSIS AND TREATMENT OF URINARY SYSTEM TUMORS. RENAL CANCER |
Lymphadenectomy in patients with renal-cell carcinoma |
(Rus)
|
